Skip to main content
Veterinary Medicines

Parvoruvax suspensija injekcijām cūkām

Authorised
  • Porcine parvovirus, strain K22, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated

Product identification

Medicine name:
Parvoruvax suspensija injekcijām cūkām
Active substance:
  • Porcine parvovirus, strain K22, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain K22, Inactivated
    2.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/02/1437
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."